Pharma

High-cost drug claims and coverage surged in 2023: report

Canadian Drug Insurance Pooling Corporation members saved over $946 million in out-of-pocket drug costs through extended policy plans in 2023

High-cost drug claims and coverage surged in 2023: report

Drug experts criticize Canada's drug approval system

"The price thing is a red herring," says former Patented Medicine Prices Review Board head, calling out delays in drug approvals

Drug experts criticize Canada's drug approval system

Pharma giant's stock rises after strong Q4 results and 2025 sales forecast

Novo Nordisk faces pressure from Eli Lilly, but its latest earnings and sales outlook push shares higher

Pharma giant's stock rises after strong Q4 results and 2025 sales forecast

Improving the prior authorization process

Founder of PAFA highlights how they're helping to streamline the PA process for payers

Improving the prior authorization process

Young Canadians face rising chronic disease rates, Sun Life report warns

Diabetes and high blood pressure claims surge among younger adults, highlighting urgent health concerns

Young Canadians face rising chronic disease rates, Sun Life report warns

Are biosimilars the saving grace for plan sponsors?

EVP at Beneva on how biosimilars plays a key role in their cost savings strategy

Are biosimilars the saving grace for plan sponsors?